Selenium and Pregnancy

Maternal selenium status declines sharply during pregnancy. In selenium-poor regions of the world, the mother’s normal everyday intake of selenium is not adequate to meet the additional needs of the fetus. In such circumstances, maternal selenium status can reach critically low levels. Meanwhile, selenium supplementation has shown positive effects on the immune system, especially in pregnancy [Schomburg 2021].

Pregnant woman needs extra selenium
Biomarkers of selenium status decline in pregnancy and can reach critically low concentrations. Sufficiently high selenium status is important for an adequate immune response during pregnancy. Furthermore, selenium deficiency in pregnancy is associated with an increased risk of autoimmune disease, e.g., postpartum thyroid disorder.

In a letter to the Deutsches Ärzteblatt International, Mücke et al urge that doctors pay extra attention to the selenium status of patients in stressful situations, e.g., pregnancy, chronic or acute illness, or convalescence. They note that there is a clear risk of selenium deficiency during pregnancy. Also after giving birth, new mothers living in selenium-poor regions will likely need selenium supplementation. They will likely need extra selenium to cope with the challenging post-partum conditions [Mücke 2021; Schomburg 2021]. read more

Selenoprotein P Status and Colorectal Cancer Mortality

Selenium deficiency, especially as manifested in low circulating levels of selenoprotein P, is associated significantly with an increased risk of colorectal cancer incidence and mortality [Pal 2024; Brezina 2025]. SELENOP is a selenium-dependent glycoprotein that is the primary transporter of selenium to the tissues and organs. SELENOP also acts to reduce oxidative stress and systemic inflammation [Schöttker 2024; Brezina 2025].

Newspaper article about cancer
Colorectal cancer risk is elevated in selenium and SELENOP deficiency. Serum SELENOP concentration is perhaps the single most useful parameter for prognosis once the diagnosis has been made. SELENOP concentrations below 2.5 mg/L indicate severe deficiency. Concentrations below 5.0 mg/L suggest elevated risk.

In the Colorectal Cancer Study of Austria (CORSA Study), researchers analyzed data from 519 participants (n = 153 tumor-free controls, n = 255 patients with adenomas, and n = 111 patients with colorectal cancer). The median age of the study participants was 65 years. Nearly two-thirds of the study participants were male. The study participants’ median plasma selenium concentration was a very low 65.7 mcg/L. Their median SELENOP concentration was also low:  2.7 mg/L. During a median follow-up period of 5,424 days (almost 15 years), there were 210 deaths (40 %) [Brezina 2025]. read more